Related Experiment Video
Updated: Jun 3, 2026

Capturing Actively Produced Microbial Volatile Organic Compounds from Human-Associated Samples with Vacuum-Assisted Sorbent Extraction
Published on: June 1, 2022
A chemometric study on human breath mass spectra for biomarker identification in cystic fibrosis
L Bennett1, L Ciaffoni, W Denzer
1Oxford Centre for Respiratory Medicine, Churchill Hospital, Old Road, Headington OX3 7LJ, UK.
Abstract:
Alveolar breath samples from a small case-control study population have been collected and measured via ion-molecule reaction mass spectrometry, and a constructive statistical approach to the identification of volatile biomarkers has been formulated by applying multivariate statistical methods on the mass spectra. The nature of the data is such that the number of variables largely exceeds the observations, representing a typical experimental scenario when breath analysis is conducted using mass spectrometry. Principal components analysis has been performed on the high dimensional dataset of molecular abundances, providing evidence of case separation and reducing the number of functional discriminators by almost 90%. Afterwards, a deductive approach based on a binary regression was conducted on the reduced dataset, providing an entirely reliable case discrimination model exclusively depending on the concentrations in the breath mixture of 3 out of a total of 97 metabolites.
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
MALDI-TOF Mass Spectrometry
Mass Spectrum
Mass Spectrum: Interpretation

